Inventor · disambiguated record
Kaoru Shimokata
Also filed as: SHIMOKATA KAORU
0 granted patents·4 pending applications·0 citations·filing 2003–2011
Files withDAIICHI PURE CHEMICALS CO LTD3
Top patents by PatentIndex Score
4 records- 0165US2009263818A1Method of estimating the risk of expression of adverse drug reaction caused by the administration of a compound, which is either metabolized per se by UGT1A1 enzyme or whose metabolic intermediate is metabolized by the enzymeDAIICHI PURE CHEMICALS CO LTD·Filed 2009·Application pending·0 cites
- 0259US2011151474A1Method of estimating the risk of expression of adverse drug reaction caused by the administration of a compound, which is either metabolized per se by ugt1a1 enzyme or whose metabolic intermediate is metabolized by the enzymeDAIICHI PURE CHEMICALS CO LTD·Filed 2011·Application pending·0 cites
- 0358US2007082357A1Method of estimating the risk of expression of adverse drug reaction caused by the administration of a compound, which is either metabolized per se by UGT1A1 enzyme or whose metabolic intermediate is metabolized by the enzymeDAIICHI PURE CHEMICALS CO LTD·Filed 2006·Application pending·0 cites
- 0456US2004058363A1Method of estimating the risk of expression of adverse drug reaction caused by the administration of a compound, which is either metabolized per se by UGT1A1 enzyme or whose metabolic intermediate is metabolized by the enzymeFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kaoru Shimokata files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →